Gaipa, Giuseppe
Gaipa, Giuseppe
DIPARTIMENTO DI MEDICINA CLINICA E PREVENZIONE (attivo dal 10/07/2006 al 30/09/2012)
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study
2022 Verbeek, M; Buracchi, C; Laqua, A; Nierkens, S; Sedek, L; Flores-Montero, J; Hofmans, M; Sobral de Costa, E; Novakova, M; Mejstrikova, E; Barrena, S; Kohlscheen, S; Szczepanowski, M; Kulis, J; Oliveira, E; Jugooa, R; de Jong, A; Szczepanski, T; Philippe, J; van Dongen, J; Orfao, A; Bruggemann, M; Gaipa, G; van der Velden, V
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome
2022 Oliveira, E; Costa, E; Ciudad, J; Gaipa, G; Sedek, Ł; Barrena, S; Szczepanski, T; Buracchi, C; Silvestri, D; Siqueira, P; Mello, F; Torres, R; Oliveira, L; Fay-Neves, I; Sonneveld, E; van der Velden, V; Mejstrikova, E; Ribera, J; Conter, V; Schrappe, M; van Dongen, J; Land, M; Orfao, A
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies
2022 Capelli, C; Frigerio, S; Lisini, D; Nava, S; Gaipa, G; Belotti, D; Cabiati, B; Budelli, S; Lazzari, L; Bagnarino, J; Tanzi, M; Comoli, P; Perico, N; Introna, M; Golay, J
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency
2021 Saettini, F; Poli, C; Vengoechea, J; Bonanomi, S; Orellana, J; Fazio, G; Rodriguez III, F; Noguera, L; Booth, C; Jarur-Chamy, V; Shams, M; Iascone, M; Vukic, M; Gasperini, S; Quadri, M; Seijas, A; Rivers, E; Mauri, M; Badolato, R; Cazzaniga, G; Bugarin, C; Gaipa, G; Kroes, W; Moratto, D; van Oostaijen-Ten Dam, M; Baas, F; van der Maarel, S; Piazza, R; Coban-Akdemir, Z; Lupski, J; Yuan, B; Chinn, I; Daxinger, L; Biondi, A
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
2021 Caracciolo, D; Riillo, C; Ballerini, A; Gaipa, G; Lhermitte, L; Rossi, M; Botta, C; Duroyon, E; Grillone, K; Cantafio, M; Buracchi, C; Alampi, G; Gulino, A; Belmonte, B; Conforti, F; Golino, G; Juli, G; Altomare, E; Polera, N; Scionti, F; Arbitrio, M; Iannone, M; Martino, M; Correale, P; Talarico, G; Di Rora, A; Ferrari, A; Concolino, D; Sestito, S; Pensabene, L; Giordano, A; Hildinger, M; Di Martino, M; Martinelli, G; Tripodo, C; Asnafi, V; Biondi, A; Tagliaferri, P; Tassone, P
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?
2020 Magnani, C; Tettamanti, S; Alberti, G; Pisani, I; Biondi, A; Serafini, M; Gaipa, G
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways
2020 Bonaccorso, P; Bugarin, C; Buracchi, C; Fazio, G; Biondi, A; Lo Nigro, L; Gaipa, G
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia
2019 Sedek, L; Theunissen, P; Sobral da Costa, E; van der Sluijs-Gelling, A; Mejstrikova, E; Gaipa, G; Sonsala, A; Twardoch, M; Oliveira, E; Novakova, M; Buracchi, C; van Dongen, J; Orfao, A; van der Velden, V; Szczepanski, T
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse
2018 Good, Z; Sarno, J; Jager, A; Samusik, N; Aghaeepour, N; Simonds, E; White, L; Lacayo, N; Fantl, W; Fazio, G; Gaipa, G; Biondi, A; Tibshirani, R; Bendall, S; Nolan, G; Davis, K
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges
2018 Gaipa, G; Buracchi, C; Biondi, A
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia
2018 Sarno, J; Savino, A; Buracchi, C; Palmi, C; Pinto, S; Bugarin, C; Jager, A; Bresolin, S; Barber, R; Silvestri, D; Israeli, S; Dyer, M; Cazzaniga, G; Nolan, G; Biondi, A; Davis, K; Gaipa, G
Linking cell function with perfusion: Insights from the transcatheter delivery of bone marrow-derived CD133 + cells in ischemic refractory cardiomyopathy trial (RECARDIO) 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology
2018 Bassetti, B; Carbucicchio, C; Catto, V; Gambini, E; Rurali, E; Bestetti, A; Gaipa, G; Belotti, D; Celeste, F; Parma, M; Righetti, S; Biava, L; Arosio, M; Bonomi, A; Agostoni, P; Scacciatella, P; Achilli, F; Pompilio, G
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.
2018 Cerrito, M; De Giorgi, M; Pelizzoni, D; Bonomo, S; Digiacomo, N; Scagliotti, A; Bugarin, C; Gaipa, G; Grassilli, E; Lavitrano, M; Giovannoni, R; Bidoli, P; Cazzaniga, M
Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice
2017 Sammali, E; Alia, C; Vegliante, G; Colombo, V; Giordano, N; Pischiutta, F; Boncoraglio, G; Barilani, M; Lazzari, L; Caleo, M; De Simoni, M; Gaipa, G; Citerio, G; Zanier, E
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL
2017 Savino, A; Sarno, J; Trentin, L; Vieri, M; Fazio, G; Bardini, M; Bugarin, C; Fossati, G; Davis, K; Gaipa, G; Izraeli, S; Meyer, L; Nolan, G; Biondi, A; Te Kronnie, G; Palmi, C; Cazzaniga, G
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia
2017 Biondi, A; Magnani, C; Tettamanti, S; Gaipa, G; Biagi, E
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation
2017 Introna, M; Lussana, F; Algarotti, A; Gotti, E; Valgardsdottir, R; Micò, C; Grassi, A; Pavoni, C; Ferrari, M; Delaini, F; Todisco, E; Cavattoni, I; Deola, S; Biagi, E; Balduzzi, A; Rovelli, A; Parma, M; Napolitano, S; Sgroi, G; Marrocco, E; Perseghin, P; Belotti, D; Cabiati, B; Gaipa, G; Golay, J; Biondi, A; Rambaldi, A
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro
2017 Chisci, E; De Giorgi, M; Zanfrini, E; Testasecca, A; Brambilla, E; Cinti, A; Farina, L; Kutryb Zając, B; Bugarin, C; Villa, C; Grassilli, E; Combi, R; Gaipa, G; Cerrito, M; Rivolta, I; Smolenski, R; Lavitrano, M; Giovannoni, R
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
2016 Romano, G; Santi, L; Bianco, M; Giuffrè, M; Pettinato, M; Bugarin, C; Garanzini, C; Savarese, L; Leoni, S; Cerrito, M; Leone, B; Gaipa, G; Grassilli, E; Papa, M; Lavitrano, M; Giovannoni, R